Literature DB >> 21496520

Unresectable multifocal omental and peritoneal inflammatory myofibroblastic tumor in a child: revisiting the role of adjuvant therapy.

Arianna Bertocchini1, Cristina Lo Zupone2, Francesco Callea3, Fabrizio Gennari1, Annalisa Serra4, Lidia Monti2, Jean de Ville de Goyet5.   

Abstract

Inflammatory myofibroblastic tumor is an uncommon lesion, also called pseudotumor, with a variable natural course from benign with spontaneous regression to mimicking malignant tumors. We report a case of diffuse peritoneal and omental pseudotumor in a 10-year-old boy characterized by aggressive behavior at the onset followed by stability after subtotal resection and chemotherapy. Total excision was not possible because of the tumor dissemination over the whole peritoneal surface. Adjuvant antiinflammatory drug (ketorolac tromethamine) and chemotherapy (methotrexate-vinblastine followed by ifosfamide-adriamycin and ifosfamide alone) were helpful to obtain rapidly complete resolution of clinical symptoms and anatomic stability of the residual lesions. Long-term evolution, in the absence of continued therapy, has been characterized by progressive involution and reduction of the residual masses.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21496520     DOI: 10.1016/j.jpedsurg.2011.01.007

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  14 in total

1.  Two Cases of Infantile Intra-abdominal Inflammatory Myofibroblastic Tumor.

Authors:  Soo-Hong Kim; Yong Hoon Cho; Hae Young Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2014-06-30

2.  Successful combination chemotherapy for metastatic inflammatory myofibroblastic tumor: A case report.

Authors:  Kyoko Inadomi; Hozumi Kumagai; Kotoe Takayoshi; Hiroshi Ariyama; Hitoshi Kusaba; Akihiro Nishie; Hidetaka Yamamoto; Ken Takase; Mamoru Tanaka; Kosuke Sagara; Yuta Okumura; Kenta Nio; Michitaka Nakano; Shuji Arita; Yoshinao Oda; Koichi Akashi; Eishi Baba
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

3.  Inflammatory myofibroblastic tumor successfully treated with chemotherapy and nonsteroidals: a case report.

Authors:  Yun-Lu Tao; Zhen-Jun Wang; Jia-Gang Han; Ping Wei
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

4.  Partial response to chemotherapy in a patient with retroperitoneal inflammatory myofibroblastic tumor.

Authors:  Ming Chen; Lihua Zhang; Guochun Cao; Weidong Zhu; Xuqiu Chen; Quan Fang
Journal:  Mol Clin Oncol       Date:  2016-07-27

5.  Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center.

Authors:  Zuopeng Wang; Xiaolong Zhao; Kai Li; Wei Yao; Kuiran Dong; Xianmin Xiao; Shan Zheng
Journal:  Pediatr Surg Int       Date:  2015-11-21       Impact factor: 1.827

Review 6.  Mesenteric inflammatory myofibroblastic tumors.

Authors:  Poras Chaudhary
Journal:  Ann Gastroenterol       Date:  2015 Jan-Mar

7.  Highly Vascularized Primarily Inflammatory Pseudotumor of the Omentum in an Adult Male: A Case Report.

Authors:  Hiba Hassan El Hage Chehade; Riad Hassan Zbibo; Bassem Mahmoud Abou Hussein; Houssam Khodor Abtar
Journal:  Am J Case Rep       Date:  2016-02-12

8.  Relapsed and unresectable inflammatory myofibroblastic tumor responded to chemotherapy: A case report and review of the literature.

Authors:  Yasuhiro Maruyama; Toshirou Fukushima; Daisuke Gomi; Takashi Kobayashi; Nodoka Sekiguchi; Akiyuki Sakamoto; Shigeru Sasaki; Keiko Mamiya; Tomonobu Koizumi
Journal:  Mol Clin Oncol       Date:  2017-08-18

9.  Complete remission of ALK-negative plasma cell granuloma (inflammatory myofibroblastic tumor) of the lung induced by celecoxib: A case report and review of the literature.

Authors:  Cinderella Chavez; Mark A Hoffman
Journal:  Oncol Lett       Date:  2013-03-15       Impact factor: 2.967

10.  Imaging findings of inflammatory myofibroblastic tumor from the greater omentum: One case report.

Authors:  Wenjie Liang; Shengzhang Lin; Zhihua Chen
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.